Hepatocytes as immunological agents

Journal of Immunology

Volumn 196, Issue 1, 2016, Pages 17-21

  Crispe, Ian N ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; B7 ANTIGEN; C REACTIVE PROTEIN; CD1D ANTIGEN; CD70 ANTIGEN; CD86 ANTIGEN; FIBRINOGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 130; HAPTOGLOBIN; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SCATTER FACTOR; SERUM AMYLOID A; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IMMUNOGLOBULIN RECEPTOR;

3' UNTRANSLATED REGION; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO STUDY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; IN VIVO STUDY; INNATE IMMUNITY; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; LYMPHOCYTE PROLIFERATION; MALARIA; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROPTOSIS; REPERFUSION INJURY; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; ACUTE PHASE RESPONSE; CYTOLOGY; HEPACIVIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LIVER; LIVER TUMOR; VIROLOGY;

ACUTE-PHASE REACTION; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; LIVER; LIVER NEOPLASMS; RECEPTORS, IMMUNOLOGIC;

EID: 84953314438     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501668     Document Type: Review

References (55)

1. Lin, B., S. Chen, Z. Cao, Y. Lin, D. Mo, H. Zhang, J. Gu, M. Dong, Z. Liu, and A. Xu. 2007. Acute phase response in zebrafish upon Aeromonas salmonicida and Staphylococcus aureus infection: striking similarities and obvious differences with mammals. Mol. Immunol. 44: 295-301.
2. Bauer, M., A. T. Press, and M. Trauner. 2013. The liver in sepsis: patterns of response and injury. Curr. Opin. Crit. Care 19: 123-127.
3. Castell, J. V., M. J. Gómez-Lechón, M. David, T. Hirano, T. Kishimoto, and P. C. Heinrich. 1988. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 232: 347-350.
4. Streetz, K. L., T. Wüstefeld, C. Klein, K. J. Kallen, F. Tronche, U. A. Betz, G. Schütz, M. P. Manns, W. Müller, and C. Trautwein. 2003. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 125: 532-543.
5. Guillén, M. I., M. J. Gómez-Lechón, T. Nakamura, and J. V. Castell. 1996. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes. Hepatology 23: 1345-1352.
6. Lukowski, S. W., R. J. Fish, J. Martin-Levilain, C. Gonelle-Gispert, L. H. Bühler, P. Maechler, E. T. Dermitzakis, and M. Neerman-Arbez. 2015. Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes. Genomics 106: 107-115.
7. Xu, M. J., D. Feng, H. Wu, H. Wang, Y. Chan, J. Kolls, N. Borregaard, B. Porse, T. Berger, T. W. Mak, et al. 2015. Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3. Hepatology 61: 692-702.
8. Norris, C. A., M. He, L. I. Kang, M. Q. Ding, J. E. Radder, M. M. Haynes, Y. Yang, S. Paranjpe, W. C. Bowen, A. Orr, et al. 2014. Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli. PLoS One 9: e96053.
9. Broughan, T. A., G. F. Jin, and J. Papaconstantinou. 1996. Early gene response to hepatic ischemia reperfusion. J. Surg. Res. 63: 98-104.
10. Tiberio, L., G. A. Tiberio, L. Bardella, E. Cervi, K. Cerea, M. Dreano, G. Garotta, A. Fra, N. Montani, A. Ferrari-Bravo, et al. 2006. Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver. Cytokine 34: 131-142.
11. Kusashio, K., H. Shimizu, F. Kimura, H. Yoshidome, M. Ohtsuka, A. Kato, H. Yoshitomi, K. Furukawa, T. Fukada, and M. Miyazaki. 2009. Effect of excessive acute-phase response on liver regeneration after partial hepatectomy in rats. Hepatogastroenterology 56: 824-828.
12. Grande, M., G. F. Tucci, O. Adorisio, A. Barini, F. Rulli, A. Neri, F. Franchi, and A. M. Farinon. 2002. Systemic acute-phase response after laparoscopic and open cholecystectomy. Surg. Endosc. 16: 313-316.
13. Bauzá, G., G. Miller, N. Kaseje, N. A. Wigner, Z. Wang, L. C. Gerstenfeld, and P. A. Burke. 2011. The effects of injury magnitude on the kinetics of the acute phase response. J. Trauma 70: 948-953.
14. Seki, E., and D. A. Brenner. 2008. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48: 322-335.
15. Vodovotz, Y., S. Liu, C. McCloskey, R. Shapiro, A. Green, and T. R. Billiar. 2001. The hepatocyte as a microbial product-responsive cell. J. Endotoxin Res. 7: 365-373.
16. Galloway, E., T. Shin, N. Huber, T. Eismann, S. Kuboki, R. Schuster, J. Blanchard, H. R. Wong, and A. B. Lentsch. 2008. Activation of hepatocytes by extracellular heat shock protein 72. Am. J. Physiol. Cell Physiol. 295: C514-C520.
17. Matsumura, T., A. Ito, T. Takii, H. Hayashi, and K. Onozaki. 2000. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J. Interferon Cytokine Res. 20: 915-921.
18. Carrera-Silva, E. A., N. Guinazu, A. Pellegrini, R. C. Cano, A. Arocena, M. P. Aoki, and S. Gea. 2010. Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection. PLoS Negl. Trop. Dis. 4: e863.
19. Petrasek, J., A. Dolganiuc, T. Csak, E. A. Kurt-Jones, and G. Szabo. 2011. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology 140: 697-708.e4.
20. Foy, E., K. Li, R. Sumpter, Jr., Y. M. Loo, C. L. Johnson, C. Wang, P. M. Fish, M. Yoneyama, T. Fujita, S. M. Lemon, and M. Gale, Jr. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102: 2986-2991.
21. Ferreon, J. C., A. C. Ferreon, K. Li, and S. M. Lemon. 2005. Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J. Biol. Chem. 280: 20483-20492.
22. Brownell, J., J. Wagoner, E. S. Lovelace, D. Thirstrup, I. Mohar, W. Smith, S. Giugliano, K. Li, I. N. Crispe, H. R. Rosen, and S. J. Polyak. 2013. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes. J. Hepatol. 59: 701-708.
23. Liu, Y., J. Li, J. Chen, Y. Li, W. Wang, X. Du, W. Song, W. Zhang, L. Lin, and Z. Yuan. 2015. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J. Virol. 89: 2287-2300.
24. Guo, F., Y. Han, X. Zhao, J. Wang, F. Liu, C. Xu, L. Wei, J. D. Jiang, T. M. Block, J. T. Guo, and J. Chang. 2015. STING agonists induce an innate antiviral immune response against hepatitis B virus. Antimicrob. Agents Chemother. 59: 1273-1281.
25. Hritz, I., P. Mandrekar, A. Velayudham, D. Catalano, A. Dolganiuc, K. Kodys, E. Kurt-Jones, and G. Szabo. 2008. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48: 1224-1231.
26. Petrasek, J., A. Iracheta-Vellve, T. Csak, A. Satishchandran, K. Kodys, E. A. Kurt- Jones, K. A. Fitzgerald, and G. Szabo. 2013. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc. Natl. Acad. Sci. USA 110: 16544-16549.
27. Roychowdhury, S., M. R. McMullen, S. G. Pisano, X. Liu, and L. E. Nagy. 2013. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57: 1773-1783.
28. Takemoto, K., E. Hatano, K. Iwaisako, M. Takeiri, N. Noma, S. Ohmae, K. Toriguchi, K. Tanabe, H. Tanaka, S. Seo, et al. 2014. Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminopheninduced acute liver failure. FEBS Open Bio 4: 777-787.
29. Imaeda, A. B., A. Watanabe, M. A. Sohail, S. Mahmood, M. Mohamadnejad, F. S. Sutterwala, R. A. Flavell, and W. Z. Mehal. 2009. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119: 305-314.
30. Li, S., R. Sun, Y. Chen, H. Wei, and Z. Tian. 2015. TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression. Cancer Res. 75: 986-995.
31. Lin, K. J., T. M. Lin, C. H. Wang, H. C. Liu, Y. L. Lin, and H. L. Eng. 2013. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma. Hum. Pathol. 44: 534-541.
32. John, B., and I. N. Crispe. 2005. TLR-4 regulates CD8+ T cell trapping in the liver. J. Immunol. 175: 1643-1650.
33. Cani, P. D., S. Possemiers, T. Van de Wiele, Y. Guiot, A. Everard, O. Rottier, L. Geurts, D. Naslain, A. Neyrinck, D. M. Lambert, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103
34. Lin, R, L. Zhou, J. Zhang, and B. Wang. 2015. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Int. J. Clin. Exp. Pathol. 8: 5153-5160.
35. Chou, H. H., W. H. Chien, L. L. Wu, C. H. Cheng, C. H. Chung, J. H. Horng, Y. H. Ni, H. T. Tseng, D. Wu, X. Lu, et al. 2015. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc. Natl. Acad. Sci. USA 112: 2175-2180.
36. Seld, E., and B. Schnabl. 2012. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J. Physiol. 590: 447-458.
37. Fox, J. G., Y. Feng, E. J. Theve, A. R. Raczynski, J. L. Fiala, A. L. Doernte, M. Williams, J. L. McFaline, J. M. Essigmann, D. B. Schauer, et al. 2010. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59: 88-97
38. Wu, J., X. J. Zhang, K. Q. Shi, Y. P. Chen, Y. F. Ren, Y. J. Song, G. Li, Y. F. Xue, Y. X. Fang, Z. J. Deng, et al. 2014. Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells. Carcinogenesis 35: 155-163
39. Yanagisawa, K., S. Yue, H. J. van der Vliet, R. Wang, N. Alatrakchi, L. Golden-Mason, D. Schuppan, M. J. Koziel, H. R. Rosen, and M. A. Exley. 2013. Ex vivo analysis of resident hepatic pro-inflammatory CDld-reactive T cells and hepatocyte surface CDld expression in hepatitis C. J. Viral Hepat. 20: 556-565
40. Ishikawa, S., K. Ikejima, H. Yamagata, T. Aoyama, K. Kon, K. Arai, K. Takeda, and S. Watanabe. 2011. CDld-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J. Hepatol. 54: 1195-1204.
41. Sander, L. E., S. D. Sackett, U. Dierssen, N. Beraza, R. P. Linke, M. Muller, J. M. Blander, F. Tacke, and C. Trautwein. 2010. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207: 1453-1464.
42. Yen, B. L., M. L. Yen, P. J. Hsu, K. J. Liu, C. J. Wang, C. H. Bai, and H. K. Sytwu. 2013. Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3-Stem Cell Rep. 1: 139-151
43. Warren, A, D. G. Le Couteur, R Fraser, D. G. Bowen, G. W. McCaughan, and P. Bertolino. 2006. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44: 1182-1190.
44. Qian, S., Z. Wang, Y. Lee, Y. Chiang, C. Bonham, J. Fung, and L. Lu. 2001. Hepatocyte-induced apoptosis of activated T cells, a mechanism of liver transplant tolerance, is related to the expression of ICAM-1 and hepatic lectin. Transplant. Proc. 33: 226.
45. Ebrahimkhani, M. R., I. Mohar, and I. N. Crispe. 2011. Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology 54: 1379-1387
46. Bertolino, P., M. C. Trescol-Biemont, J. Thomas, B. Fazekas de St Groth, M. Pihlgren, J. Marvel, and C. Rabourdin-Combe. 1999. Death by neglect as a deletional mechanism of peripheral tolerance. Int. Immunol. 11: 1225-1238.
47. Benseler, V., A. Warren, M. Vo, L. E. Holz, S. S. Tay, D. G. Le Couteur, E. Breen, A. C. Allison, N. van Rooijen, C. McGuffog, et al. 2011. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc. Natl. Acad. Sci. USA 108: 16735-16740.
48. Radziewicz, H., C. C. Ibegbu, M. L. Fernandez, K. A. Workowski, K. Obideen, M. Wehbi, H. L. Hanson, J. P. Steinberg, D. Masopust, E. J. Wherry, et al. 2007. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81: 2545-2553.
49. Spahn, J., R. H. Pierce, and I. N. Crispe. 2011. Ineffective CD8(+) T-cell immunity to adeno-associated virus can result in prolonged liver injury and fibrogenesis. Am. J. Pathol. 179: 2370-2381.
50. Tay, S. S., Y. C. Wong, D. M. McDonald, N. A. Wood, B. Roediger, F. Sierro, C. Mcguffog, I. E. Alexander, G. A. Bishop, J. R. Gamble, et al. 2014. Antigen expression level threshold tunes the fate of CD 8 T cells during primary hepatic immune responses. Proc. Natl. Acad. Sci. USA 111: E2540-E2549
51. Ando, K., L. G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152: 3245-3253
52. Smith, C. M., N. S. Wilson, J. Waithman, J. A. Villadangos, F. R. Carbone, W. R Heath, and G. T. Belz. 2004. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 5: 1143-1148.
53. + T cell help in liver-stage malaria. Front. Microbiol. 5: 617
54. Dini, L., F. Autuori, A. Lentini, S. Oliverio, and M. Piacentini. 1992. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEES Lett. 296: 174-178.
55. Wuensch, S. A, J. Spahn, and I. N. Crispe. 2010. Direct, help-independent priming of CD8+ T cells by adeno-associated virus-transduced hepatocytes. Hepatology 52: 1068-1077.